At Tacit, our technology is inspired by the flow of genetic information.
We repurpose naturally-existing systems to repair RNA, creating the most broadly-applicable and safest way to treat genetic disease.
RNA is the future and the potential is unbounded.
Splicing-Directed Repair™ technology fixes defective genes while avoiding the risks associated with other gene editing approaches.
Delivering on the promise of gene therapy
Splicing-Directed Repair™ is the first broadly-applicable and non-immunogenic way to repair mutations. Our mission is to maximize the impact of our platform by developing treatments for tens of devastating illnesses.
